Work

How Does Big Data Analytics Drive Supply Chain Resilience in Pharmaceuticals? Exploring the Roles of Supply Chain Risk and Ambidexterity

Year: 2026

Type: article

Abstract: Background: The primary objective of this study is to investigate the influence of big data analytics (BDA) on supply chain (SC) risk, SC ambidexterity, and SC resilience. It further examines the effects of SC risk and SC ambidexterity on SC resilience and explores their mediating roles in the BDA–SC resilience relationship. Despite growing interest in BDA and resilience, limited empirical research has addressed these linkages in pharmaceutical distribution, particularly in emerging economies such as Jordan. Methods: A quantitative research strategy was adopted, employing a survey-based methodology. Data were obtained from 204 managers in pharmaceutical distribution companies in Jordan. Results: The findings indicate that BDA reduces SC risk and positively influences SC ambidexterity and SC resilience. Furthermore, SC risk and SC ambidexterity positively affect SC resilience. Notably, both variables partially mediate the BDA–SC resilience relationship, with ambidexterity showing a stronger effect. Conclusions: Grounded in the resource-based view and the dynamic capability view, this study provides empirical evidence that BDA enhances SC resilience primarily by fostering ambidexterity and mitigating risks. By clarifying the distinct mediating roles of SC risk and SC ambidexterity, the research extends theory and offers practical insights for managers seeking to build more resilient pharmaceutical SCs.

Source: Logistics

DOI: 10.3390/logistics10010014

Authors: Sara Sami Al-Nuimat, Zu’bi M. F. Al-Zu’bi, Ayman Bahjat Abdallah

Institution: University of Jordan

Language: English

Topic: Supply Chain Resilience and Risk Management

Subfield: Strategy and Management

Field: Business, Management and Accounting

Domain: Social Sciences

SDG: Industry, innovation and infrastructure

Open Access status: gold

Estimated APC paid: $1,689